On the Issue of Antibiotic-Associated Diarrhea Prevention in Children

T.O. Kriuchko, I.M. Nesinа, N.H. Astakhova, V.V. Voloshina, T.N. Ponomarenko

Abstract


The article presents the results of our own researches of therapeutic and preventive effectiveness of symbiotic drug Colifagina PRO against the background of antibacterial therapy in children with respiratory diseases. The need to correct dysbiotic violations using antibiotic therapy is not in doubt. Inclusion in the combination therapy with antibiotics of probiotic correction with symbiotic agent Colifagina PRO in patients with acute respiratory disorders enabled to prevent antibiotic-associated diarrhea in children and contributed to a more rapid regression of the main symptoms of the disease, normalization of stool nature and frequency.

Keywords


antibiotic-associated diarrhea; antibiotic therapy; respiratory disease; children; Colifagina PRO.

References


Kaplan J.B. Biofilm Dispersal: Mechanisms, Clinical Implications, and Potential Therapeutic Uses // J. Dent. Res. — 2010. — 89(3). — Р. 205-218.

Takenaka S. Direct Visualization of Spatial and Temporal Patterns of Antimicrobial Action within Model Oral Biofilms / Shoji Takenaka, Harsh M. Trivedi, Audrey Corbin, Betsey Pitts, Philip S. Stewart // Applied and environmental microbiology. — 2008, Mar. — Р. 1869-1875.

Hua J. Activity of antimicrobial peptide mimetics in the oral cavity: II. Activity against periopathogenic biofilms and anti-inflammatory acti­vity / J. Hua, R.W. Scott, G. Diamond // Mol. Oral. Microbiol. — 2010. — 25(6). — Р. 426-432.

Isolauri E., Kalliomaki M., Laitinen K., Salminen S. Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease // Curr. Pharm. Des. — 2008. — 14. — P. 1368-1375.

Proal A.D., Albert P.J., Marshall T.G. Autoimmune disease in the era of the metagenome // Autoimmunity Reviews. — 2009.

Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., Gordon J.I. The human microbiome project // Nature. — 2007. — 449(7164). — P. 804-810.

Goodacre R. Metabolomics of a superorganism // J. Nutr. — 2007. — 137 (1 Suppl). — 259S–266S.

Turck D., Bernet J.P., Marx J. et al. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population // J. Pediatr. Gastroenterol. Nutr. — 2003. — № 37. — Р. 22-26.

Майданник В.Г. Антибиотикассоциированная диарея, связанная с Clostridium difficile // Здоров’я України. — 2010. — С. 20-22.

LaRosa M., Bottaro G., Gulino N. Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructooligosaccharides in children: a multicentric doubleblind vs. placebo study // Minerva Pediatr. — 2003. — № 55. — Р. 447-452.

McFarland L.V. Probiotics and Diarrhea // Ann. Nutr. Metab. — 2010. — № 57 (suppl. 1). — Р. 10-11.

Ардатская М.А. Пре- и пробиотики в коррекции микроэкологических нарушений кишечника // Фарматека. Гастроэнтерология/гепатология. — 2011. — № 12. — С. 62-9.

Крючко Т.О., Пода О.А., Шликова О.А., Ізмайлова О.В. Генетичні та імунологічні маркери розвитку жирової дегенерації печінки у дітей та підлітків з метаболічним синдромом // Перинатология и педиатрия. — 2014. — № 4(60). — С. 87-93.

Johnston B.C., Goldenberg J.Z., Vandvik P.O. et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea // Cochrane Database Syst. Rev. — 2011. —11. — CD004827.

Pozzoni P., Riva A., Bellatorre A.G. et al. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial // Am. J. Gastroenterol. — 2012. — 107. — P. 922-931.

Friedman G. The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea and Clostridium difficile colitis // Gastroenterol Clin. North. Am. — 2012. — 41. — P. 763-779.

Guandalini S. Probiotics for prevention and treatment of diarrhea // J. Clin. Gastroenterol. — 2011. — 45 (Suppl). — P. 149-153.

Wanke M., Szajewska H. Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial // J. Pediatr. — 2012. — 161. — P. 40-43.

Gil-Campos M., Lopez M.A., Rodriguez-Benitez M.V. et al. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1–6 months of age: a randomized controlled trial // Pharmacol. Res. — 2012. — 65. — P. 231-238.

Deshpande G., Shripad R., Patole S. Progress in the field of probiotics: year 2011 // Current Opinion in Gastroenterology. — 2011. — 27. — P. 13-18.

Ritchie M.L., Romanuk T.N. A meta-analysis of probiotic efficacy for gastrointestinal diseases // PLoS One. — 2012. — 7. — e34938.

Майданник В.Г. Антибіотикотерапія позалікарняної пневмонії у дітей: огляд сучасних клінічних рекомендацій // Здоров’я України. — 2014. — № 23–24. — С. 23-25; 37-38.




DOI: https://doi.org/10.22141/2224-0551.4.64.2015.75319

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru